Department of Ophthalmology, Mayo Clinic, Rochester, MN 55905, USA.
Am J Ophthalmol. 2010 Apr;149(4):672-6. doi: 10.1016/j.ajo.2009.11.004. Epub 2010 Feb 6.
To report the test-retest variability of two health-related quality-of-life instruments: the new Adult Strabismus 20 (AS-20) and the National Eye Institute 25-item Visual Function Questionnaire (NEI VFQ-25), in adults with strabismus.
Prospective case series.
Fifty-five adult patients in a clinical practice with stable strabismus completed the AS-20 and the NEI VFQ-25 at 2 visits, without intervening treatment. Questionnaires were completed the second time either at a subsequent office visit, immediately before surgery, or by mail. Intraclass correlation coefficients were calculated. Ninety-five percent limits of agreement and 95% confidence intervals around the 95% limits of agreement also were calculated.
There was excellent agreement of overall questionnaire scores for the AS-20 (intraclass correlation coefficient, 0.92) and NEI VFQ-25 (intraclass correlation coefficient, 0.94). The 95% limits of agreement for overall scores were 14.3 points (95% confidence interval, 10.9 to 17.7) for the AS-20 and 11.1 points (95% confidence interval, 8.5 to 13.8) for the NEI VFQ-25. The lower test-retest variability of the VFQ-25 seemed to be partly the result of ceiling effects with many scores at the normal end of the range.
The new AS-20 and the NEI VFQ-25 show excellent test-retest reliability in adults with strabismus. Change exceeding 95% limits of agreement (14 points on the AS-20 and 11 points on the VFQ-25) is indicative of real change in an individual patient. The AS-20 may be more useful than the VFQ-25 because it is less prone to ceiling effects in adults with strabismus.
报告两种与健康相关的生活质量工具的测试-重测变异性:新的成人斜视 20 项(AS-20)和国家眼科研究所 25 项视觉功能问卷(NEI VFQ-25),用于斜视的成年人。
前瞻性病例系列。
55 名在临床实践中患有稳定斜视的成年患者在 2 次就诊时完成了 AS-20 和 NEI VFQ-25,没有介入治疗。第二次在随后的门诊就诊时、手术前或通过邮件完成问卷。计算了组内相关系数。还计算了 95%一致性界限和 95%一致性界限周围的 95%置信区间。
AS-20(组内相关系数,0.92)和 NEI VFQ-25(组内相关系数,0.94)的总体问卷评分具有极好的一致性。总体评分的 95%一致性界限为 AS-20 为 14.3 分(95%置信区间,10.9 至 17.7),NEI VFQ-25 为 11.1 分(95%置信区间,8.5 至 13.8)。VFQ-25 的较低测试-重测变异性部分是由于许多分数处于正常范围末端的天花板效应所致。
新的 AS-20 和 NEI VFQ-25 在斜视的成年人中表现出极好的测试-重测可靠性。超过 95%一致性界限(AS-20 上为 14 分,VFQ-25 上为 11 分)的变化表明个体患者的真实变化。AS-20 可能比 VFQ-25 更有用,因为它在斜视的成年人中不太容易受到天花板效应的影响。